Failed Johnson & Johnson COVID Vaccine No Longer Available in US

Listen to the article

After much fanfare for its initial rollout over two years ago, the J&J jab is no longer on offer for Americans.

“Janssen COVID-19 Vaccine is no longer available in the U.S. All remaining U.S. government stock of Janssen COVID-19 Vaccine expired May 7, 2023. Dispose of any remaining Janssen COVID-19 Vaccine in accordance with local, state, and federal regulations,” the quietly updated CDC guidance reads.

What a total waste of taxpayer money. How much good could have been done with all that cash flushed down the proverbial toilet into J&J coffers — all for a poorly conceived product that never worked as promised and carried severe side effect risks.

Via NBC News, May 5, 2022:

U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s Covid-19 vaccine due to a rare but serious risk of blood clots.

The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine. U.S. authorities for months have recommended that Americans starting their Covid-19 vaccinations use the Pfizer or Moderna shots instead.

Had the FDA done its due diligence in requiring Johnson & Johnson to put its product through the same vetting process that every vaccine in history prior to 2020 had undergone, of course, it would never have made it to market in the first place.



Please think about donating below. 




Related Posts